Skip to main content
OpenTrials
Completed

NCT Number: NCT04797169

Noom Health for Weight Management

The goals of the study are to use the Noom mobile app to help individuals with weight loss and weight loss maintenance. This project will test the comparative efficacy of Noom Health vs. Noom Digital Health for weight loss, quality of life, psychosocial functioning, and self-reported health status. It is expected that use of Noom Health will show post-intervention success relative to Noom Digital Health as well as long-term success with weight loss maintenance. Data is expected to show that participants who are older, have less support, have more health conditions, and with more psychosocial problems will benefit more from Noom Health. It is also expected that confidence in the ability to lose weight will produce more successful results in Noom Health vs. Noom Digital Health.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Weight Loss Body Weight Body Weight Changes Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Psychiatry, Eating and Weight Disorders Program

New York, 10028, United States

About this study

A total of 600 subjects will be enrolled in a randomized-controlled trial comparing the Noom app (Noom Health) to a digital control (Noom Digital Health) with 6 months of intervention and 6 months active maintenance in both groups. Measures will include demographics, psychosocial measures, height/weight, waist circumference, weight loss history/practices, health care practices/utilization, and quality of life.

Participants will complete informed consent and interviews via a HIPAA-compliant videoconference (Zoom) and other questionnaires via a REDCap interface. All participants will complete screening/baseline procedures to determine eligibility and initial information. Subsequently, they will be randomized to one of the groups for a 6-month intervention and 6- month maintenance period (12 months total).

In Noom Health, participants will be encouraged to use the app multiple times per day to log eating episodes, physical activity and weight. Coaches will also interact with participants directly through the app. In Noom Digital Health, participants will use a simplified version to log eating episodes and weight. Both conditions will receive the same weight loss advice content.

During the intervention, participants will complete monthly satisfaction surveys. Additionally, follow-up measures will be conducted at 7 time points (Screening/Baseline, 1 month, 4 months, 6 months, 12 months, 18 months, 24 months, and 30 months).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must be interested in the Noom app
  • BMI > 27 kg/m2
  • Ages of 18 and 60 at entry to the study
  • Speak English

Exclusion criteria

  • Contraindication to smartphone use (e.g., seizures from prior smartphone use, do not own a smartphone)
  • Acute suicide risk
  • Pregnant or planning to become pregnant during the study
  • Current Noom use

Treatment and study plan

Noom Health

Behavioral

In Noom Health, participants will be encouraged to use the Noom app multiple times a day to log eating episodes, physical activity and weight. They will also have the ability to interact with coaches to receive advice and feedback specific to weight loss.

Noom Digital Health

Behavioral

In Noom Digital Health, participants will use a simplified version to log eating episodes and weight. Both conditions will receive the same weight loss advice content.

Primary outcomes

  1. Change in Weight From Baseline

    Time frame: Baseline, 6 months and 30 Months

    Weight at 6 months and 30 months as compared to baseline. Weight will be documented using staff-led Zoom calls and taken with the participant's home scale.

Secondary outcomes

  1. Change in Caloric Intake Using the Automated Self-Administered Recall System (ASA24) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    Caloric intake at 30 months as compared to baseline. Caloric intake will be measured using the ASA24 dietary recall system.

  2. Change in Dietary Behavior Using the Eating Disorder Examination Questionnaire (EDE-Q) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    EDE-Q global score at 30 months as compared to baseline. Dietary restraint, eating, shape, and weight concerns are measured with the EDE-Q. These subscales are summed and then divided by the total number of subscales (4) to create a global score. Scores range from 0 to 52 with higher scores indicating higher severity.

  3. Change in Physical Activity Using the International Physical Activity Questionnaire (IPAQ) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    Physical activity at 30 months as compared to baseline. The IPAQ includes 27 items and determines a MET value for time spent in an average week completing different levels of activity including vigorous or moderate physical activity, walking, and sitting. One MET is the energy spent sitting at rest.

  4. Change in Depression Using the Depression Anxiety Stress Scales (DASS) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    Depression subscale score at 30 months as compared to baseline. DASS is a 42-item self-report scale of negative emotional states with subscales of depression, anxiety, and stress. Each subscale is scored 0-42, with total score from 0-126. Higher scores indicate more severe psychological distress.

  5. Change in Anxiety Using the Depression Anxiety Stress Scales (DASS) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    Anxiety subscale score at 30 months as compared to baseline. DASS is a 42-item self-report scale of negative emotional states with subscales of depression, anxiety, and stress. Each subscale is scored 0-42, with total score from 0-126. Higher scores indicate more severe psychological distress.

  6. Change in Stress Using the Depression Anxiety Stress Scales (DASS) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    Stress subscale score at 30 months as compared to baseline. DASS a 42-item self-report scale of negative emotional states with subscales of depression, anxiety, and stress. Each subscale is scored 0-42, with total score from 0-126. Higher scores indicate more severe psychological distress.

  7. Change in Sleep Impairment Using the PROMIS Sleep Related Impairment Survey From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    Sleep impairment at 30 months as compared to baseline. The PROMIS Sleep Related Impairment v.1.0 is a 16-item self-report measure of perceived functioning during waking hours in relation to tiredness and trouble sleeping. A raw score is calculated by summing all individual items and is translated into a T-score with standard error (SE). A T-score of 50 indicates normal impairment compared to the general population, scores above 50 indicate more impairment.

  8. Change in Physical Composite Score (PCS) Using the Short-Form-36 (SF-36) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    PCS at 30 months as compared to baseline. The SF-36 is a 36-item self-report health-related quality of life assessment of physical functioning, limitations, energy, emotional well-being, social functioning, pain and general health. Scores range from 17.2- 66.7 with lower scores indicating worse quality of life related to physical health.

  9. Change in Mental Composite Score (MCS) Using the Short-Form-36 (SF-36) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    MCS at 30 months as compared to baseline. The SF-36 is a 36-item self-report health-related quality of life assessment of physical functioning, limitations, energy, emotional well-being, social functioning, pain and general health. Scores range from 12.7-64.2 with lower scores indicating worse quality of life related to mental health.

  10. Change in Self-Efficacy for Healthy Eating Using the Diet Self-Efficacy Scale (DIET-SE) From Baseline to 30 Months

    Time frame: Baseline and 30 Months

    Self-efficacy at 30 months as compared to baseline. The DIET-SE is an 11-item self-report assessment of healthy eating with scales specific to temptations, social/internal factors, and negative emotional related to resistance. The score ranges from 0 - 40 with higher scores indicating more self-efficacy.

  11. Adherence to Intervention Measured Using a Percentage of the Total Number of Available App Features Used at 6 Months

    Time frame: 6 Months

    The percent of available features on the app, expected verses completed at 6 months

  12. Number of Participants With 12-Month Completion Status

    Time frame: 12 Months

    Attrition at 12 months as compared to number randomized at baseline documented using completion status

  13. Percent of Successful Technological Fixes

    Time frame: Baseline and 12 Months

    App compatibility will be examined by calculating the percent of successful technological fixes at 12 months as compared to baseline. The type of technological problems encountered by participants while using the app and any fixes needed will be categorized.

  14. Change in CDC NCHS National Health Interview Survey

    Time frame: Baseline and 30 Months

    Changes in health status from baseline to 30-months as measured by questions from the CDC NCHS National Health Interview Survey. Using an adapted version of the CDC NCHS National Health Interview Survey, the survey includes 4 questions about healthcare utilization. Items identify type of healthcare sought and frequency. The frequency of provider visits will be calculated to determine healthcare utilization. A frequency score of zero indicates no healthcare utilized. There is no upper limit for the frequency.

Sponsors and collaborators

Lead sponsor

Icahn School of Medicine at Mount Sinai

Other

Collaborators

  • Noom Inc.

Registry information

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Mar 15, 2021
Registry last updated
Aug 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.